Algeria has been officially validated by the World Health Organization as having eliminated trachoma as a public health problem, marking a major milestone in global health efforts.
With this achievement, Algeria becomes the 10th country in the WHO African Region and the 29th globally to reach the target.
Trachoma, a bacterial eye infection caused by Chlamydia trachomatis, remains the leading infectious cause of blindness worldwide. The disease is still endemic in about 30 countries, affecting an estimated 1.9 million people with blindness or visual impairment, while nearly 97 million people remain at risk.
The infection spreads through contact with infected eye discharge, often via hands, clothing, or flies. Repeated infections can lead to scarring of the eyelid, causing eyelashes to turn inward and damage the eye — a painful condition that can result in permanent blindness.
Describing the achievement as historic, Tedros Adhanom Ghebreyesus said Algeria’s success reflects decades of sustained commitment.
“Algeria’s elimination of trachoma is a historic triumph that connects the past, present, and future of public health,” he said. “This milestone proves that with sustained political will and on-the-ground leadership, we can eliminate neglected tropical diseases and build a healthier future for all.”
Algeria’s fight against trachoma dates back to the early 20th century, beginning with the establishment of the Pasteur Institute in 1909. Following independence, local health experts, led by Mohamed Aouchiche, strengthened national efforts, which were further supported by the introduction of free public healthcare services in 1974.
Over the years, the country implemented the WHO-recommended SAFE strategy, which includes surgery for advanced cases, mass antibiotic distribution, improved hygiene practices, and better access to water and sanitation.
To accelerate progress, Algeria launched a targeted strategy between 2013 and 2015, focusing on 12 southern provinces where the disease remained prevalent.
By 2022, WHO-compliant surveys confirmed that elimination thresholds had been achieved nationwide. Additional door-to-door screenings were conducted in a few areas to ensure full coverage before final validation.
In December 2025, Algeria’s Ministry of Health submitted evidence to WHO confirming that all criteria for elimination had been met. Strong health systems, including school health programmes, improved sanitation, and widespread access to eye care services, were cited as key factors behind the success.
Mohamed Janabi described the milestone as transformative.
“Trachoma devastates individuals and communities, with blindness causing significant economic and social hardship. Algeria’s achievement demonstrates that eliminating neglected tropical diseases is possible with consistent and coordinated efforts,” he said.
WHO has advised continued surveillance to prevent a resurgence of the disease and is supporting Algerian authorities in monitoring previously affected communities.
Also speaking, Algeria’s Health Minister, Mohamed Seddik Ait Messaoudene, said the milestone reflects decades of national commitment.
“This achievement represents a collective victory and underscores Algeria’s unwavering commitment to public health,” he said. “It was made possible through the dedication of health professionals, strong partnerships, and sustained government support.”
